Advisory Committee on Immunization Practices
Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Abstract
This report provides recommendations for use of the newly licensed hepatitis A vaccines (HAVRIX, manufactured by SmithKline Beecham Biologicals, and VAQTA, manufactured by Merck & Company, Inc.) in persons > or = 2 years of age and updates previous recommendations for use of immune globulin (IG) for protection against hepatitis A (superseding MMWR 1990;39[No. RR-2]:1-5). For preexposure protection, hepatitis A vaccine can now be used instead of IG in many circumstances; for postexposure prophylaxis, the recommendations for IG use are unchanged.
Source and rights
Published by MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1996. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- Advisory Committee on Immunization Practices
- Published
- 1996
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
- PubMed
- 9005304
- Added to Prognia
- 24 July 2026